Emily Barker

403 total citations
12 papers, 85 citations indexed

About

Emily Barker is a scholar working on Pediatrics, Perinatology and Child Health, Oncology and Epidemiology. According to data from OpenAlex, Emily Barker has authored 12 papers receiving a total of 85 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Emily Barker's work include Maternal and fetal healthcare (4 papers), Reproductive Health and Contraception (3 papers) and Cervical Cancer and HPV Research (3 papers). Emily Barker is often cited by papers focused on Maternal and fetal healthcare (4 papers), Reproductive Health and Contraception (3 papers) and Cervical Cancer and HPV Research (3 papers). Emily Barker collaborates with scholars based in United States, United Kingdom and Netherlands. Emily Barker's co-authors include R. N. Dejong, Nancy B. Kiviat, King K. Holmes, D. A. Eschenbach, Pippa Corrie, Chemtai Mungo, Andrea Marshall, Janet Dunn, Paul Lorigan and Mark R. Middleton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and American Journal of Public Health.

In The Last Decade

Emily Barker

11 papers receiving 77 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Barker United States 6 37 26 13 12 11 12 85
María‐Jesús Pascual Spain 4 17 0.5× 55 2.1× 14 1.1× 9 0.8× 12 1.1× 5 88
Devleta Balić Bosnia and Herzegovina 7 26 0.7× 10 0.4× 24 1.8× 7 0.6× 11 1.0× 14 128
Peter Achara Nigeria 4 44 1.2× 29 1.1× 16 1.2× 11 0.9× 2 0.2× 7 74
Fatima Zahra Laamırı Morocco 9 34 0.9× 34 1.3× 13 1.0× 13 1.1× 2 0.2× 26 156
Ilana Cass United States 6 6 0.2× 19 0.7× 45 3.5× 12 1.0× 7 0.6× 13 106
Aruyaru Stanley Mwenda Kenya 4 12 0.3× 17 0.7× 17 1.3× 6 0.5× 3 0.3× 10 62
C Fotopoulou United Kingdom 3 52 1.4× 27 1.0× 11 0.8× 10 0.8× 3 0.3× 8 85
Mahmoud Abdel-Aziz Egypt 5 21 0.6× 10 0.4× 7 0.5× 3 0.3× 7 0.6× 23 87
Kavita Mandrelle India 4 19 0.5× 16 0.6× 23 1.8× 5 0.4× 2 0.2× 18 100
Laura Tucker United States 6 40 1.1× 24 0.9× 3 0.2× 5 0.4× 3 0.3× 12 82

Countries citing papers authored by Emily Barker

Since Specialization
Citations

This map shows the geographic impact of Emily Barker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Barker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Barker more than expected).

Fields of papers citing papers by Emily Barker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Barker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Barker. The network helps show where Emily Barker may publish in the future.

Co-authorship network of co-authors of Emily Barker

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Barker. A scholar is included among the top collaborators of Emily Barker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Barker. Emily Barker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Premkumar, Ashish, Julie Chor, Beth A. Plunkett, et al.. (2024). Duration of Induction of Labor for Second-Trimester Medication Abortion and Adverse Outcomes. Obstetrics and Gynecology. 144(3). 367–376.
2.
Ludwig, Daniel R., et al.. (2023). CT imaging of intrauterine devices (IUD): expected findings, unexpected findings, and complications. Abdominal Radiology. 49(1). 237–248. 5 indexed citations
3.
4.
Barker, Emily, et al.. (2022). Complications of second‐trimester medical termination of pregnancy for fetal anomalies compared with intrauterine fetal demise. International Journal of Gynecology & Obstetrics. 160(1). 145–149. 2 indexed citations
5.
Mungo, Chemtai, et al.. (2021). Integration of cervical cancer screening into HIV/AIDS care in low income countries: a moral imperative. ecancermedicalscience. 15. 1237–1237. 6 indexed citations
6.
Robinson, Matthew J., Kévin Vervier, Simon R. Harris, et al.. (2021). Abstract 1783: Precision microbiome profiling identifies a novel biomarker predictive of Immune Checkpoint Inhibitor response in multiple cohorts and a potent therapeutic consortium of bacteria. Cancer Research. 81(13_Supplement). 1783–1783. 1 indexed citations
7.
Mungo, Chemtai, et al.. (2021). Feasibility and Acceptability of Smartphone-Based Cervical Cancer Screening Among HIV-Positive Women in Western Kenya. JCO Global Oncology. 7(7). 686–693. 9 indexed citations
8.
Robinson, Matthew, Kévin Vervier, Simon R. Harris, et al.. (2020). 673 Precision microbiome mapping identifies a microbiome signature predictive of Immune checkpoint inhibitor response across multiple research study cohorts. Regular and Young Investigator Award Abstracts. A404.1–A404. 5 indexed citations
9.
Mellor, Catriona, et al.. (2020). Wellbeing Wednesdays: nurse-led clinic for improving physical health care in a general adolescent inpatient unit. British Journal of Nursing. 29(4). 230–235. 1 indexed citations
10.
Fernandes, Ricardo, Andrea Marshall, Paul Lorigan, et al.. (2018). 25-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial. British Journal of Cancer. 119(7). 793–800. 12 indexed citations
11.
Corrie, Pippa, Andrea Marshall, Paul Lorigan, et al.. (2017). Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence: Final results for the AVAST-M trial.. Journal of Clinical Oncology. 35(15_suppl). 9501–9501. 7 indexed citations
12.
Holmes, King K., et al.. (1980). High prevalence of cervical dysplasia in STD clinic patients warrants routine cytologic screening.. American Journal of Public Health. 70(11). 1212–1214. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026